Abstract
Monocytes play an important role in inflammation and atherosclerosis; however, the molecular details underlying these diverse functions are not completely understood. Proteomic analysis of monocytes can provide new insights into their biological role in coronary artery disease (CAD). Twenty angiographically confirmed male, CAD patients (≥50% stenosis) attending cardiology clinic of Nehru Hospital, PGIMER, Chandigarh, and who were not receiving any lipid lowering therapy and 20 TMT negative subjects who served as controls were enrolled in the study. Circulating monocytes isolated from overnight fasting blood samples were analyzed by 2D gel electrophoresis (pH 4–7), and differentially expressed protein spots were subjected to mass spectrometry and identification of proteins. We observed 333 ± 40 protein spots in monocytes from patients and 312 ± 20 in controls; out of which 63 protein spots showed altered intensity in CAD patients. Thirteen spots showed fivefold increased and two protein spots showed fivefold decreased expression in CAD group as compared to control group, respectively. Two proteins showing decreased expression in monocytes from CAD patients were identified as: (i) glutathione transferase and (ii) heat shock protein 70 KDa. Proteins showing increased expression in CAD patients were identified as: (i) vimentin, (ii) mannose binding lectin receptor protein, and (iii) S100A8 calcium-binding protein. The results of our study offer identification of several proteins in monocytes which can provide new perspectives in role of monocytes in pathogenesis of atherosclerosis.
Similar content being viewed by others
References
Rader DJ, Daugherty A (2008) Translating molecular discoveries into new therapies for atherosclerosis. Nature 451:904–913. doi:10.1038/nature06796
Libby P (2002) Inflammation in atherosclerosis. Nature 20:868–874. doi:10.1038/nature01323
Anderson L (2005) Candidate-based proteomics in the search for biomarkers of cardiovascular disease. J Physiol 563:23–60. doi:10.1113/jphysiol.2004.080473
Arab S, Gramolini AO, Ping P, Kislinger T, Stanley B, van Eyk J, Ouzounian M, MacLennan DH, Emili A, Liu PP (2006) Cardiovascular proteomics: tools to develop novel biomarkers and potential applications. J Am Coll Cardiol 48:1733–1741. doi:10.1016/j.jacc.2006.06.063
Arrell DK, Neverova I, Van Eyk JE (2001) Cardiovascular proteomics: evolution and potential. Circ Res 8:763–773. doi:10.1161/hh0801.090193
Jin M, Opalek JM, Marsh CB, Wu HM (2004) Proteome comparison of alveolar macrophages with monocytes reveals distinct protein characteristics. Am J Respir Cell Mol Biol 31:322–329. doi:10.1165/rcmb.2004-0080OC
Hryniewicz-Jankowska A, Choudhary PK, Goodman SR (2007) Variation in monocyte proteome. Exp Biol Med 7:967–976
Jin M, Diaz PT, Bourgeois T, Eng C, Marsh CB, Wu HM (2006) Two-dimensional gel proteome reference map of blood monocytes. Proteome Sci 4:16. doi:10.1186/1477-5956-4-16
Barderas MG, Tunon J, Darde VM, De la Cuesta F, Duran MC, Nacher JJ, Tarín N, López-Bescós L, Egido J, Vivanco F (2007) Circulating human monocytes in the acute coronary syndrome express a characteristic proteomic profile. J Proteome Res 6:876–886. doi:10.1021/pr0601990
Barderas MG, Tuñón J, Dardé VM, De la Cuesta F, Jiménez-Nácher JJ, Tarín N, López-Bescós L, Egido J, Vivanco F (2009) Atorvastatin modifies the protein profile of circulating human monocytes after an acute coronary syndrome. Proteomics 7:1982–1993. doi:10.1002/pmic.200700583
Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248–254
Hayes JD, Strange RC (1995) Potential contribution of the glutathione S-transferase supergene family to resistance to oxidative stress. Free Radic Res 3:193–207
Yang Y, Trent MB, He N, Lick SD, Zimniak P, Awasthi YC, Boor PJ (2004) Glutathione-S-transferase A4–4 modulates oxidative stress in endothelium: possible role in human atherosclerosis. Atherosclerosis 173:211–221. doi:10.1016/j.atherosclerosis.2003.12.023
Cao Z, Li Y (2002) Chemical induction of cellular antioxidants affords marked protection against oxidative injury in vascular smooth muscle cells. Biochem Biophys Res Commun 292:50–57. doi:10.1006/bbrc.2002.6614
Doney AS, Lee S, Leese GP, Morris AD, Palmer CN (2005) Increased cardiovascular morbidity and mortality in type 2 diabetes is associated with the glutathione S transferase theta-null genotype: a Go-DARTS study. Circulation 22:2927–2934. doi:10.1161/CIRCULATIONAHA.104.509224
Torzewski M, Ochsenhirt V, Kleschyov AL, Oelze M, Daiber A, Li H, Rossmann H, Tsimikas S, Reifenberg K, Cheng F, Lehr HA, Blankenberg S, Förstermann U, Münzel T, Lackner KJ (2007) Deficiency of glutathione peroxidase-1 accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 4:850–857. doi:10.1161/01.ATV.0000258809.47285.07
Vicente-Manzanares M, Sánchez-Madrid F (2004) Role of the cytoskeleton during leukocyte responses. Nat Rev Immunol 4:110–122. doi:10.1038/nri1268
Geiben-Lynn R, Kursar M, Brown NV, Addo MM, Shau H, Lieberman J, Luster AD, Walker BD (2003) HIV-1 antiviral activity of recombinant natural killer cell enhancing factors, NKEF-A and NKEF-B, members of the peroxiredoxin family. J Biol Chem 278:1569–1574. doi:10.1074/jbc.M209964200
Logan MR, Odemuyiwa SO, Moqbel R (2003) Understanding exocytosis in immune and inflammatory cells: the molecular basis of mediator secretion. J Allergy Clin Immunol 5:923–932. doi:10.1067/mai.2003.1573
Jordens I, Marsman M, Kuijl C, Neefjes J (2005) Rab proteins, connecting transport and vesicle fusion. Traffic 6:1070–1077. doi:10.1111/j.1600-0854.2005.00336
Qin H, Ishiwata T, Wang R, Kudo M, Yokoyama M, Naito Z, Asano G (2000) Effects of extracellular matrix on phenotype modulation and MAPK transduction of rat aortic smooth muscle cells in vitro. Exp Mol Pathol 69:79–90. doi:10.1006/exmp.2000.2321
Jurcevic S, Ainsworth ME, Pomerance A, Smith JD, Robinson DR, Dunn MJ, Yacoub MH, Rose ML (2001) Antivimentin antibodies are an independent predictor of transplant-associated coronary artery disease after cardiac transplantation. Transplantation 7:886–892
Kang JH, Kim H, Choi MS, Lee WH, Huh TL, Park YB, Moon BJ, Kwon OS (2006) Proteome analysis of human monocytic THP-1 cells primed with oxidized low-density lipoproteins. Proteomics 6:1261–1273. doi:10.1002/pmic.200500290
Heidenthal AK, Weber PC, Lottspeich F, Hrboticky N (2000) The binding in vitro of modified LDL to the intermediate filament protein vimentin. Biochem Biophys Res Commun 267:49–53. doi:10.1006/bbrc.1999.1940
Keller TT, van Leuven SI, Meuwese MC, Wareham NJ, Luben R, Stroes ES, Hack CE, Levi M, Khaw KT, Boekholdt SM (2006) Serum levels of mannose-binding lectin and the risk of future coronary artery disease in apparently healthy men and women. Arterioscler Thromb Vasc Biol 10:2345–2350. doi:10.1161/01.ATV.0000240517.69201.77
Gadjeva M, Takahashi K, Thiel S (2004) Mannan-binding lectin–a soluble pattern recognition molecule. Mol Immunol 41:113–121. doi:10.1016/j.molimm.2004.03.015
Turner MW (1996) Mannose-binding lectin: the pluripotent molecule of the innate immune system. Immunol Today 17:532–540
Petersen SV, Thiel S, Jensenius JC (2001) The mannan-binding lectin pathway of complement activation: biology and disease association. Mol Immunol 38:133–149. doi:10.1016/S0161-5890(01)00038-4
Roos A, Bouwman LH, van Gijlswijk-Janssen DJ, Faber-Krol MC, Stahl GL, Daha MR (2001) Human IgA activates the complement system via the mannan-binding lectin pathway. J Immunol 5:2861–2868
Ogden CA, de Cathelineau A, Hoffmann PR, Bratton D, Ghebrehiwet B, Fadok VA, Henson PM (2001) C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 194:781–795. doi:10.1084/jem.194.6.781
Ghiran I, Barbashov SF, Klickstein LB, Tas SW, Jensenius JC, Nicholson-Weller A (2000) Complement receptor 1/CD35 is a receptor for mannan-binding lectin. J Exp Med 192:1797–1808. doi:10.1084/jem.192.12.1797
Speidl WS, Exner M, Amighi J, Kastl SP, Zorn G, Maurer G, Wagner O, Huber K, Minar E, Wojta J, Schillinger M (2005) Complement component C5a predicts future cardiovascular events in patients with advanced atherosclerosis. Eur Heart J 26:2294–2299. doi:10.1093/eurheartj/ehi339
Oksjoki R, Jarva H, Kovanen PT, Laine P, Meri S, Pentikainen MO (2003) Association between complement factor H and proteoglycans in early human coronary atherosclerotic lesions: implications for local regulation of complement activation. Arterioscler Thromb Vasc Biol 23:630–636. doi:10.1161/01.ATV.0000057808.91263.A4
Zhu J, Quyumi AA, Wu H, Csako G, Rott D, Zalles-Ganley A, Ogunmakinwa J, Halcox J, Epstein SE (2003) Increased serum levels of heat shock protein 70 are associated with low risk of coronary artery disease. Arterioscler Thromb Vasc Biol 23:1055–1059. doi:10.1161/01.ATV.0000074899.60898.FD
Kol A, Bourcier T, Lichtman AH, Libby P (1999) Chlamydial and human heat shock protein 60s activate human vascular endothelium, smooth muscle cells, and macrophages. J Clin Invest 103:571–577. doi:10.1172/JCI5310
Shamaei-Tousi A, Stephens JW, Bin R, Cooper JA, Steptoe A, Coates ARM, Henderson B, Humphries SE (2006) Association between plasma levels of heat shock protein 60 and cardiovascular disease in patients with diabetes mellitus. Eur Heart J 27:1565–1570. doi:10.1093/eurheartj/ehl081
Kanwar RK, Kanwar JR, Wang D, Ormrod DJ, Krissansen GW (2001) Temporal expression of heat shock proteins 60 and 70 at lesion-prone sites during atherogenesis in ApoE-deficient mice. Arterioscler Thromb Vasc Biol 12:1991–1997. doi:10.1161/hq1201.100263
Han Z, Truong QA, Park S, Breslow JL (2003) Two Hsp70 family members expressed in atherosclerotic lesions. Proc Natl Acad Sci USA 3:1256–1261. doi:10.1073/pnas.252764399
Svensson PA, Asea A, Englund MC, Bausero MA, Jernås M, Wiklund O, Ohlsson BG, Carlsson LM, Carlsson B (2006) Major role of HSP70 as a paracrine inducer of cytokine production in human oxidized LDL treated macrophages. Atherosclerosis 185:32–38. doi:10.1016/j.atherosclerosis.2005.05.007
Westaby S, Johnson P, Parry AJ, Blomquist S, Solen JO, Alling C, Pillai R, Taggart DP, Grebenik C (1996) Serum S100 protein: a potential marker for cerebral events during cardiopulmonary bypass. Ann Thorac Surg 61:88–92. doi:10.1016/0003-4975(95)00904-3
Ramasamy R, Yan SF, Schmidt AM (2005) The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond. Trends Cardiovasc Med 15:237–243. doi:10.1016/j.tcm.2005.08.003
Rammes A, Roth J, Goebeler M, Kelmpt M, Sorg C (1997) Myeloid related protein (MRP8) and MRP-14, calcium binding proteins of the S100 family are secreted by activated monocytes via novel tubulin-dependent pathway. J Biol Chem 272:9496–9502. doi:10.1074/jbc.272.14.9496
McCormick MM, Rahimi F, Bobryshev YV, Gaus K, Zreiqat H, Cai H, Lord RSA, Geczy CL (2005) S100A8 and S100A9 in human arterial wall. Implications for atherogenesis. J Biol Chem 280:41521–41529. doi:10.1074/jbc.M509442200
Acknowledgment
This research project was funded by the Department of Biotechnology (DBT), New Delhi, India (DBT ref. no. BT/PR8001/MED/12/306/2006).
Conflict of interests
The authors declare that they have no conflict of interests.
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Poduri, A., Bahl, A., Talwar, K.K. et al. Proteomic analysis of circulating human monocytes in coronary artery disease. Mol Cell Biochem 360, 181–188 (2012). https://doi.org/10.1007/s11010-011-1055-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11010-011-1055-3